COMMUNIQUÉS West-GlobeNewswire

Chief Medical Director Kari Syrjänen will retire from Biohit Oyj

31/12/2018 - 13:00

Biohit Oyj 31.12.2018 12:00 Biohit’s management team member Chief Medical Director Kari Syrjänen will retire as planned 31 st of December 2018. Kari Syrjänen has been employed by Biohit since 2013. ”I would like to [...]

GW Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference

31/12/2018 - 13:00

LONDON and CARLSBAD, Calif., Dec. 31, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]

Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc.

31/12/2018 - 13:00

Harrow Health, Inc. Name Reflects the Company’s Commitment to the Future of Healthcare SAN DIEGO, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (formerly known as Imprimis Pharmaceuticals, Inc.) (NASDAQ: IMMY) [...]

Eve & Co Announces First Shipment of Dried Cannabis Product and Files Financial Results for the Three and Twelve Month Periods Ended October 31, 2018

31/12/2018 - 13:00

TORONTO, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that it has completed its first shipment of dried cannabis product [...]

Arrayit Corporation Announces Chief Executive Officer Letter to Shareholders

31/12/2018 - 11:30

Sunnyvale, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces a letter to shareholders from Arrayit Chief Executive Officer Rene Schena. The [...]

Terveystalo Plc: Terveystalo appoints Petri Bono as Chief Medical Officer

31/12/2018 - 10:46

Terveystalo Plc Stock Exchange release 31 December 2018 at 11:45 a.m. EET Petri Bono, born 1970, M.D., Ph.D., has been appointed as Chief Medical Officer as of 1 February 2019. He becomes a member of the Terveystalo [...]

Rule 2.9 Announcement

31/12/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 31 December 2018 [...]

Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

31/12/2018 - 04:23

Company Release no. 24/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 December 2018 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]

Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual Tablet

29/12/2018 - 01:46

SAN DIEGO, Dec. 28, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its fast- [...]

MedMira Reports First Quarter Results

29/12/2018 - 00:00

HALIFAX, Nova Scotia, Dec. 28, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2018. Q1 FY2019 Financial Results Highlights Profit [...]

Veloxis Pharmaceuticals Announces Financial Calendar for 2019

28/12/2018 - 23:12

Company Release no. 23/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 28 December 2018 Veloxis Pharmaceuticals Announces Financial Calendar for 2019 Veloxis Pharmaceuticals A/S (OMX: VELO) today announced its [...]

Helix BioPharma Corp. Closes Final Tranche of Private Placement

28/12/2018 - 23:05

CAD2,262,000 in total private placement financings closed in December 2018 for a total of CAD6,424,800 in calendar 2018 RICHMOND HILL, Ontario, Dec. 28, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP [...]

AIT Nearing Definitive Agreement to License Commercial Rights of Its Novel Ventilator Compatible Nitric Oxide Generator and Delivery System for Use in the Hospital Setting in the United States and a Second Country

28/12/2018 - 22:56

AIT to receive up to $32.5 million in up-front and regulatory milestones Additionally, AIT to receive a 15%-20% royalty on annual gross profit Partner to receive rights to all indications at nitric oxide concentrations [...]

RUDDCO Inc. Announces the Addition of a Bio-chemist and Toxicologist to the Staff

28/12/2018 - 16:00

MIAMI, Dec. 28, 2018 (GLOBE NEWSWIRE) -- Ruddco Inc., a Florida based company in conjunction with Orange Hill Limited under a joint venture agreement, is announcing an expansion of cannabis operations and the opening of [...]

Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThrax™

28/12/2018 - 15:01

GAITHERSBURG, Md., Dec. 28, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today the submission of an application to the U.S. Food and Drug Administration (FDA) for potential emergency use of [...]

Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference

28/12/2018 - 15:00

DUBLIN - December 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. Omar Ishrak, [...]

American Cannabis Company, Inc. Announces Filing of Form 10-K

28/12/2018 - 14:30

DENVER, CO, Dec. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary [...]

Agritek Holdings, Inc. Announces First Sales of its Brand MD Vapes With New Broad Spectrum Zero THC Hemp CBD Oil Distillate and Full Spectrum "Crystal Resistant" CBD Oil Under Licenses in Colorado and Puerto Rico

28/12/2018 - 14:30

LOS ANGELES, CA, Dec. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]

Gala Pharmaceutical Receives Temporary State License for Cannabis Testing

28/12/2018 - 14:00

IRVINE, Calif., Dec. 28, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical California Inc., a subsidiary of Gala Pharmaceutical, Inc. (Ticker: GLPH), today announced it has received a Temporary License from the State of [...]